Gossamer Bio (GOSS) Fundamental Analysis: Revenue, Earnings & Valuation

3.97 / 10

Netural

Fundamental analysis scores 4.0/10, indicating inadequate financial health. Profit‑MV and Cash‑MV are positive, but Current Assets Turnover is low and Income Tax ratio is weak. Gross margin is high, yet overall weakness suggests limited upside.

Analysis Checks(7/10)

Revenue-MV

Value-2.04

Score1/3

Weight12.22%

1M Return5.44%

Inventory turnover ratio

Value106.57

Score3/3

Weight14.84%

1M Return6.65%

Gross profit margin (%)

Value100.00

Score2/3

Weight3.15%

1M Return1.67%

Profit-MV

Value0.68

Score2/3

Weight13.96%

1M Return6.36%

Income tax / Total profit (%)

Value0.05

Score1/3

Weight0.34%

1M Return0.21%

Current assets turnover ratio

Value0.20

Score0/3

Weight-2.60%

1M Return-1.61%

Fixed assets turnover ratio

Value1310.03

Score3/3

Weight2.96%

1M Return1.76%

Cost of sales ratio (%)

Value57.03

Score3/3

Weight7.37%

1M Return4.08%

Asset-MV

Value-0.55

Score2/3

Weight34.09%

1M Return13.10%

Cash-MV

Value0.03

Score2/3

Weight13.67%

1M Return6.19%

Is GOSS undervalued or overvalued?

GOSS scores 3.97/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -351.49% net margin, -0.53 P/E ratio, -0.73 P/B ratio, and -200.00% earnings growth, these metrics solidify its Netural investment rating.